The Administrative Core is designed to provide overall leadership for the program project. The P.I., with the support of an administrative secretary, organizes and manages the different components of the program. This includes frequent interactions with the Co-P.l., Lead Investigators, and Core Leaders, internal program review and planning, organization of work-in-progress meetings, external review, scientific seminar series, and overall representation of the needs of the scientific and administrative programs. Core A communicates with the external and internal advisors, the Cancer Center Directors of the Wistar Institute, University of Pennsylvania, Memorial Sloan Kettering Cancer Center, and the NCI program staff. This Core serves the needs of the entire program on the etiology, progression and therapy of melanoma for the institutions on the Wistar/Penn and MSKCC campuses.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA025874-32
Application #
8450873
Study Section
Special Emphasis Panel (ZCA1-RPRB-O)
Project Start
Project End
Budget Start
2013-04-01
Budget End
2014-03-31
Support Year
32
Fiscal Year
2013
Total Cost
$115,727
Indirect Cost
$22,488
Name
Wistar Institute
Department
Type
DUNS #
075524595
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Qin, Jie; Rajaratnam, Rajathees; Feng, Li et al. (2015) Development of organometallic S6K1 inhibitors. J Med Chem 58:305-14
Bastian, Boris C (2014) The molecular pathology of melanoma: an integrated taxonomy of melanocytic neoplasia. Annu Rev Pathol 9:239-71
Simpson, R Mark; Bastian, Boris C; Michael, Helen T et al. (2014) Sporadic naturally occurring melanoma in dogs as a preclinical model for human melanoma. Pigment Cell Melanoma Res 27:37-47
Vultur, A; Villanueva, J; Krepler, C et al. (2014) MEK inhibition affects STAT3 signaling and invasion in human melanoma cell lines. Oncogene 33:1850-61
Wähler, Kathrin; Ludewig, Anja; Szabo, Patrick et al. (2014) Rhenium Complexes with Red-Light-Induced Anticancer Activity. Eur J Inorg Chem 2014:807-811
Wiesner, Thomas; He, Jie; Yelensky, Roman et al. (2014) Kinase fusions are frequent in Spitz tumours and spitzoid melanomas. Nat Commun 5:3116
Yeh, Iwei; Mully, Thaddeus W; Wiesner, Thomas et al. (2014) Ambiguous melanocytic tumors with loss of 3p21. Am J Surg Pathol 38:1088-95
Wang, Tao; Ge, Yingbin; Xiao, Min et al. (2014) SECTM1 produced by tumor cells attracts human monocytes via CD7-mediated activation of the PI3K pathway. J Invest Dermatol 134:1108-18
Dörr, Markus; Meggers, Eric (2014) Metal complexes as structural templates for targeting proteins. Curr Opin Chem Biol 19:76-81
Botton, Thomas; Yeh, Iwei; Bastian, Boris C (2014) Melanoma BRAF fusions--letter. Clin Cancer Res 20:6631

Showing the most recent 10 out of 331 publications